Macular Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 128 total displayed.

Most recent content

Original Contributions
Macular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple Sclerosis

Bryn M. Burkholder; Benjamin Osborne; Michael J. Loguidice; Esther Bisker; Teresa C. Frohman; Amy Conger; John N. Ratchford; Christina Warner; Clyde E. Markowitz; Dina A. Jacobs; Steven L. Galetta; Gary R. Cutter; Maureen G. Maguire; Peter A. Calabresi; Laura J. Balcer; Elliot M. Frohman
Arch Neurol 2009; 66: 1366-1372. [Abstract] [Full text] [Full text PDF]  

Original Contributions
Optical Coherence Tomography in Clinically Isolated Syndrome: No Evidence of Subclinical Retinal Axonal Loss

Olivier Outteryck; Hélène Zephir; Sabine Defoort; Marie Bouyon; Philippe Debruyne; Ikram Bouacha; Didier Ferriby; Arnaud Lacour; Pierre Labalette; Jerome de Seze; Patrick Vermersch
Arch Neurol 2009; 66: 1373-1377. [Abstract] [Full text] [Full text PDF]  

Clinical Sciences
A New Macular Dystrophy With Anomalous Vascular Development, Pigment Spots, Cystic Spaces, and Neovascularization

Vinit B. Mahajan; Stephen R. Russell; Edwin M. Stone
Arch Ophthalmol 2009; 127: 1449-1457. [Abstract] [Full text] [Full text PDF]  

Clinical Sciences
The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study System for Evaluation of Optical Coherence Tomograms: SCORE Study Report 4

Amitha Domalpally; Barbara A. Blodi; Ingrid U. Scott; Michael S. Ip; Neal L. Oden; Andreas K. Lauer; Paul C. VanVeldhuisen; for the SCORE Study Investigator Group
Arch Ophthalmol 2009; 127: 1461-1467. [Abstract] [Full text] [Full text PDF]  

Epidemiology
Prediction of Proliferative Diabetic Retinopathy With Hemoglobin Level

Baqiyyah N. Conway; Rachel G. Miller; Ronald Klein; Trevor J. Orchard
Arch Ophthalmol 2009; 127: 1494-1499. [Abstract] [Full text] [Full text PDF]  

Past content

Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5

The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1101-1114. [Abstract] [Full text] [Full text PDF] [ eTable ]  

Clinical Trials
A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6

The SCORE Study Research Group
Arch Ophthalmol 2009; 127: 1115-1128. [Abstract] [Full text] [Full text PDF]  

Epidemiology
The Relation of Markers of Inflammation and Endothelial Dysfunction to the Prevalence and Progression of Diabetic Retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy

Barbara E. K. Klein; Michael D. Knudtson; Michael Y. Tsai; Ronald Klein
Arch Ophthalmol 2009; 127: 1175-1182. [Abstract] [Full text] [Full text PDF]  

Editorials
SCOREing in Retinal Venous Occlusive Disease

Rajendra S. Apte
Arch Ophthalmol 2009; 127: 1203-1204. [Extract] [Full text] [Full text PDF]  

Ophthalmic Molecular Genetics
Phenotypic Variability Due to a Novel Glu292Lys Variation in Exon 8 of the BEST1 Gene Causing Best Macular Dystrophy

Elliott H. Sohn; Peter J. Francis; Jacque L. Duncan; Richard G. Weleber; David A. Saperstein; Donald F. Farrell; Edwin M. Stone
Arch Ophthalmol 2009; 127: 913-920. [Abstract] [Full text] [Full text PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13